IBX 0.00% 7.0¢ imagion biosystems limited

Ann: 2021 Annual Report to Shareholders, page-27

  1. 791 Posts.
    lightbulb Created with Sketch. 203
    Study completion expected in 2022. Not first half, Q3.. just 2022. My god. 10 more months. That’ll be 15 patients in 24 months. Whoever was behind the design and rollout of this trial should really be shown the door..
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.